Talwalkar V R, Scheiner M, Hedges L K, Butler M G, Schwartz H S
Department of Orthopedics and Rehabilitation, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2550, USA.
Cancer Genet Cytogenet. 1998 Jul 15;104(2):111-4. doi: 10.1016/s0165-4608(97)00452-4.
Defective mismatch repair has been detected in human colorectal and endometrial carcinomas which exhibit microsatellite instability (MIN). The purpose of this study was to search for MIN in melanoma. Paraffin-embedded neoplastic and non-neoplastic control cells were obtained from 20 untreated individuals with cutaneous malignant melanoma. Breslow thickness ranged from 0.2-7.4 mm (mean 1.4). Cells were carefully scraped from glass slides so that tumor and control DNA could be isolated and then amplified by polymerase chain reaction (PCR) at seven separate microsatellites localized to specific chromosome regions: 1p22 (D1S187), 5q11.2-13.3 (D5S107), 6q21-23.3 (D6S357), 9p21 (IFNA), 11p15.2 (D11S861), 17p13.1 (D17S786), and 18q11 (D18S34). Heterozygosity indices were > or = 0.70. Loci from these chromosome regions were chosen because of cytogenetic abnormalities reported in melanoma (1p, 6q, 9p), location of common oncogenes (11p-HRAS, 17p-TP53), or use in other MIN studies (5q, 18q). Five individuals (25%) demonstrated MIN. There was no correlation with tissue thickness. One individual demonstrated MIN at two loci and one individual demonstrated loss of heterozygosity. The results indicate that MIN occurs in melanoma, albeit less frequently than reported in carcinomas.
在表现出微卫星不稳定性(MIN)的人类结直肠癌和子宫内膜癌中已检测到错配修复缺陷。本研究的目的是在黑色素瘤中寻找MIN。从20名未经治疗的皮肤恶性黑色素瘤患者中获取石蜡包埋的肿瘤和非肿瘤对照细胞。Breslow厚度范围为0.2 - 7.4毫米(平均1.4毫米)。小心地从载玻片上刮下细胞,以便分离肿瘤和对照DNA,然后通过聚合酶链反应(PCR)在位于特定染色体区域的七个不同微卫星处进行扩增:1p22(D1S187)、5q11.2 - 13.3(D5S{107})、6q21 - 23.3(D6S357)、9p21(IFNA)、11p15.2(D11S861)、17p13.1(D17S786)和18q11(D18S34)。杂合性指数≥0.70。选择这些染色体区域的位点是因为黑色素瘤中报道的细胞遗传学异常(1p、6q、9p)、常见癌基因的位置(11p - HRAS、17p - TP53)或其他MIN研究中的使用情况(5q、18q)。五名个体(25%)表现出MIN。与组织厚度无相关性。一名个体在两个位点表现出MIN,一名个体表现出杂合性缺失。结果表明MIN在黑色素瘤中发生,尽管频率低于在癌中的报道。